Stay updated on Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial
Sign up to get notified when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.

Latest updates to the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page
- Check3 days agoChange DetectedNew navigation/help items were added to the study details page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment, and a revision tag Revision: v3.6.0. The older label Intervention / Treatment and Revision: v3.5.5 were removed, indicating a UI/navigation and versioning update.SummaryDifference0.5%

- Check10 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new release. This update reflects maintenance rather than changes to the study information.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page shows a new revision tag (v3.5.4) replacing the previous v3.5.3, signaling a version update of the page. It does not reflect changes to the study content or results.SummaryDifference0.1%

- Check53 days agoChange DetectedA revision/version string on the ClinicalTrials.gov page was updated from v3.5.2 to v3.5.3, reflecting an interface or backend site release rather than a change to the study information.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.